Keywords: Medicis, Anacor, Acne drug, Research, Development

Medicis and Anacor collaborate on acne drug development in up to $160 million deal

Article | 11 February 2011

Print This

US companies Medicis Pharmaceutical (NYSE:MRX) and Anacor Pharmaceuticals (Nasdaq: ANAC) have entered into an R&D agreement to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in